USPTO serial 76642958
MAGFECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KON, ELISSA GARBER
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MAGFECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
London EC2M 2TD, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICAL PREPARATIONS FOR NON-MEDICAL USE, NAMELY, LIPID-BASED POLYNUCLEOTIDE COMPLEXES AND LIPOSOMAL DELIVERY AGENTS FOR OTHER CHEMICALS AND CHEMICAL PREPARATIONS, FOR INDUSTRIAL, SCIENTIFIC, AGRICULTURAL, HORTICULTURAL AND FORESTRY USE; LIPOSOMAL AGENTS FOR USE IN MOLECULAR IMAGING; GADOLINIUM-CHELLATED LIPIDS; GADOLINIUM CHELATES; CONTRAST AGENTS FOR USE IN MOLECULAR IMAGING | ACTIVE | — |
| 005 | CHEMICAL PREPARATIONS, NAMELY, LIPID-BASED POLYNUCLEOTIDE COMPLEXES FOR MEDICAL, PHARMACEUTICAL AND VETERINARY USE AND LIPOSOMAL DELIVERY AGENTS FOR MEDICAL, PHARMACEUTICAL AND VETERINARY PREPARATIONS; LIPOSOMAL AGENTS FOR USE IN MOLECULAR IMAGING; GADOLINIUM-CHELLATED LIPIDS; GADOLINIUM CHELATES; CONTRAST AGENTS FOR USE IN MOLECULAR IMAGING | ACTIVE | — |
| 040 | CUSTOMIZATION OF CHEMICAL PREPARATIONS FOR NON-MEDICAL USE, NAMELY, LIPID-BASED POLYNUCLEOTIDE COMPLEXES AND LIPOSOMAL DELIVERY AGENTS FOR OTHER CHEMICALS AND CHEMICAL PREPARATIONS, FOR INDUSTRIAL, SCIENTIFIC, AGRICULTURAL, HORTICULTURAL AND FORESTRY USE; CUSTOMIZATION OF CHEMICAL PREPARATIONS, NAMELY, LIPID-BASED POLYNUCLEOTIDE COMPLEXES FOR MEDICAL, PHARMACEUTICAL AND VETERINARY USE AND LIPOSOMAL DELIVERY AGENTS FOR MEDICAL, PHARMACEUTICAL AND VETERINARY PREPARATIONS; CUSTOMIZATION SERVICES RELATING TO THE GADOLINIUM LABELING OF LIPOSOMES; CUSTOMIZATION SERVICES RELATING TO CONTRAST AGENTS FOR USE IN MOLECULAR IMAGING | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2006 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 8, 2006 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 16, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2005 | PAPER RECEIVED | — | |
| Jul 26, 2005 | NWAP | NEW APPLICATION ENTERED | — |